TD Asset Management’s Neurogene NGNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,800
| Closed | -$361K | – | 1250 |
|
|
2024
Q4 | $361K | Buy |
+15,800
| New | +$361K | ﹤0.01% | 1200 |
|
|
2019
Q4 | – | Sell |
-20,588
| Closed | -$59K | – | 1413 |
|
|
2019
Q3 | $59K | Buy |
+20,588
| New | +$59K | ﹤0.01% | 1328 |
|
|
2018
Q3 | – | Sell |
-42,547
| Closed | -$113K | – | 1447 |
|
|
2018
Q2 | $113K | Sell |
42,547
-46,917
| -52% | -$125K | ﹤0.01% | 1405 |
|
|
2018
Q1 | $1.26M | Buy |
89,464
+4,820
| +6% | +$67.9K | ﹤0.01% | 997 |
|
|
2017
Q4 | $995K | Hold |
84,644
| – | – | ﹤0.01% | 1052 |
|
|
2017
Q3 | $1.2M | Hold |
84,644
| – | – | ﹤0.01% | 989 |
|
|
2017
Q2 | $1.19M | Hold |
84,644
| – | – | ﹤0.01% | 1006 |
|
|
2017
Q1 | $1.41M | Sell |
84,644
-300
| -0.4% | -$5.01K | ﹤0.01% | 958 |
|
|
2016
Q4 | $1.4M | Buy |
84,944
+6,237
| +8% | +$103K | ﹤0.01% | 945 |
|
|
2016
Q3 | $1.05M | Buy |
+78,707
| New | +$1.05M | ﹤0.01% | 998 |
|